RNA Stock Analysis: Buy, Sell, or Hold?

RNA - Avidity Biosciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$13.47
0.10 (0.75%) β–²
5d: +2.9%
30d: -14.04%
90d: -81.34%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026

Get Alerted When RNA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

In-depth Analysis How we analyze

Valuation Analysis: RNA is currently trading at $13.47, which is considered fair relative to its 30-day fair value range of $2.06 to $39.06.

Technical Outlook: Technically, RNA is in a strong uptrend. Immediate support is located at $11.95, while resistance sits at $13.90.

Market Sentiment: RNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+85.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $2.06 - $39.06
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 85.6% below Wall St target ($25.00)

Fair Price Analysis

30-Day Fair Range $2.06 - $39.06
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $11.95
Resistance Level $13.90
Current Trend Strong Uptrend
Technical data as of Apr 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.92
Wall Street Target $25.00 (+85.6%)
Revenue Growth (YoY) -71.1%
Profit Margin -265.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 02, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael F Maclean SELL 4542 shares 2026-01-21
Arthur A Levin SELL 1758 shares 2026-01-21
W. Michael Flanagan SELL 6534 shares 2026-01-21

Unlock Insider Activity

See real-time buying/selling by company executives for RNA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$449 58 HOLD
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$94 55 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$33 45 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$101 60 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$26 55 HOLD

Advanced RNA Option Strategies

Professional options setups generated by AI based on today's RNA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RNA

RNA Technical Chart RNA Price Prediction RNA Earnings Date RNA Investment Advisor RNA Fair Price Analyzer RNA Options Advisor RNA Options Chain RNA Options Analysis RNA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals